Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults

British Journal of Haematology

Volumn 139, Issue 3, 2007, Pages 464-474

  Van Heeckeren, Willem J ^b   Fanning, Laura R ^b   Meyerson, Howard J ^a   Fu, Pingfu ^a   Lazarus, Hillard M ^b   Cooper, Brenda W ^b   Tse, William W ^b   Kindwall Keller, Tamila L ^b   Jaroscak, Jennifer ^a   Finney, Marcie R ^b   Fox, Robert M ^a   Solchaga, Luis ^a   Forster, Margaret ^b   Creger, Richard J ^b   Laughlin, Mary J ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Graft lymphocytes; Graft versus host disease; Haematopoietic stem cell transplantation; Human leucocyte antigen disparity; Umbilical cord blood transplantation

Indexed keywords

AZATHIOPRINE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GLUCOCORTICOID; INFLIXIMAB; LEUKOCYTE ANTIGEN; MELPHALAN; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD2; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PREDNISONE; PSORALEN; TACROLIMUS; THALIDOMIDE; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; ENGRAFTMENT; FEMALE; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HUMAN; MALE; MYELOABLATIVE CONDITIONING; NEUTROPHIL COUNT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROPHYLAXIS; PUVA; STEM CELL TRANSPLANTATION; SURVIVAL; UMBILICAL CORD BLOOD; WHOLE BODY RADIATION;

ACUTE DISEASE; ADULT; CHRONIC DISEASE; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; FETAL BLOOD; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING;

EID: 34848871883     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06824.x     Document Type: Article

References (56)

1. Almici, C., Carlo-Stella, C., Wagner, J.E. Rizzoli, V. (1996) Density separation and cryopreservation of umbilical cord blood cells: evaluation of recovery in short-and long-term cultures. Acta Haematologica, 95, 171 175.
2. Apperley, J.F., Jones, L., Hale, G., Waldmann, H., Hows, J., Rombos, Y., Tsatalas, C., Marcus, R.E., Goolden, A.W. Gordon-Smith, E.C. (1986) Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse. Bone Marrow Transplantation, 1, 53 66.
3. Atkinson, K., Biggs, J., Cooley, M., Farrelly, H., O'Flaherty, E., Raphael, H., Ashby, M., Concannon, A., Dodds, A. Morgan, G. (1987) A comparative study of T-cell depleted and non-depleted marrow transplantation for hematological malignancy. Australian and New Zealand Journal of Medicine, 17, 16 23.
4. Ballen, K.K. (2005) New trends in umbilical cord blood transplantation. Blood, 105, 3786 3792.
5. Barker, J.N., Davies, S.M., DeFor, T., Ramsay, N.K., Weisdorf, D.J. Wagner, J.E. (2001) Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood, 97, 2957 2961.
6. Barker, J.N., Krepski, T.P., DeFor, T.E., Davies, S.M., Wagner, J.E. Weisdorf, D.J. (2002) Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biology of Blood Marrow Transplant, 8, 257 260.
7. Champlin, R.E., Passweg, J.R., Zhang, M.J., Rowlings, P.A., Pelz, C.J., Atkinson, K.A., Barrett, A.J., Cahn, J.Y., Drobyski, W.R., Gale, R.P., Goldman, J.M., Gratwohl, A., Gordon-Smith, E.C., Henslee-Downey, P.J., Herzig, R.H., Klein, J.P., Marmont, A.M., O'Reilly, R.J., Ringden, O., Slavin, S., Sobocinski, K.A., Speck, B., Weiner, R.S. Horowitz, M.M. (2000) T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood, 95, 3996 4003.
8. Cornetta, K., Laughlin, M., Carter, S., Wall, D., Weinthal, J., Delaney, C., Wagner, J., Sweetman, R., McCarthy, P. Chao, N. (2005) Umbilical cord blood transplantation in adults: results of the prospective cord blood transplantation (COBLT). Biology of Blood Marrow Transplant, 11, 149 160.
9. Flomenberg, N., Baxter-Lowe, L.A., Confer, D., Fernandez-Vina, M., Filipovich, A., Horowitz, M., Hurley, C., Kollman, C., Anasetti, C., Noreen, H., Begovich, A., Hildebrand, W., Petersdorf, E., Schmeckpeper, B., Setterholm, M., Trachtenberg, E., Williams, T., Yunis, E. Weisdorf, D. (2004) Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood, 104, 1923 1930.
10. Fraser, C.C., Kaneshima, H., Hansteen, G., Kilpatrick, M., Hoffman, R. Chen, B.P. (1995) Human allogeneic stem cell maintenance and differentiation in a long-term multilineage SCID-hu graft. Blood, 86, 1680 1693.
11. Fraser, J.K., Cairo, M.S., Wagner, E.L., McCurdy, P.R., Baxter-Lowe, L.A., Carter, S.L., Kernan, N.A., Lill, M.C., Slone, V., Wagner, J.E., Wallas, C.H. Kurtzberg, J. (1998) Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures. Journal of Hematotherapy, 7, 521 561.
12. Gaines, B.A., Colson, Y.L., Kaufman, C.L. Ildstad, S. (1996) Facilitating cells enable engraftment of purified fetal liver stem cells in allogeneic recipients. Experimental Hematology, 24, 902 913.
13. Gandy, K.L., Domen, J., Aguila, H. Weissman, I.L. (1999) CD8+TCR+ and CD8+TCR- cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers. Immunity, 11, 579 590.
14. Gluckman, E., Rocha, V., Boyer-Chammard, A., Locatelli, F., Arcese, W., Pasquini, R., Ortega, J., Souillet, G., Ferreira, E., Laporte, J.P., Fernandez, M. Chastang, C. (1997) Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. New England Journal of Medicine, 337, 373 381.
15. Glucksberg, H., Storb, R., Fefer, A., Buckner, C.D., Neiman, P.E., Clift, R.A., Lerner, K.G. Thomas, E.D. (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation, 18, 295 304.
16. Goldman, J.M., Gale, R.P., Horowitz, M.M., Biggs, J.C., Champlin, R.E., Gluckman, E., Hoffmann, R.G., Jacobsen, S.J., Marmont, A.M. McGlave, P.B. (1988) Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Annals of Internal Medicine, 108, 806 814.
17. Grewal, S.S., Barker, J.N., Davies, S.M. Wagner, J.E. (2003) Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood, 101, 4233 4244.
18. Hamza, N.S., Lisgaris, M., Yadavalli, G., Nadeau, L., Fox, R., Fu, P., Lazarus, H.M., Koc, O.N., Salata, R.A. Laughlin, M.J. (2004) Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. British Journal Haematology, 124, 488 498.
19. Jaroscak, J.J., Laughlin, M.J. Gerson, S.L. (2001) Engraftment competition between umbilical crod blood (UCB) units in NOD/SCID mice. Blood, 98, 645a.
20. Kaplan, E.L. Meier, P. (1958) Non-parametricestimation from incomplete observations. Journal of American Statistical Association, 53, 457 481.
21. Kernan, N.A., Bordignon, C., Heller, G., Cunningham, I., Castro-Malaspina, H., Shank, B., Flomenberg, N., Burns, J., Yang, S.Y. Black, P. (1989) Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants. Blood, 74, 2227 2236.
22. Kleen, T.O., Kadereit, S., Fanning, L.R., Jaroscak, J., Fu, P., Meyerson, H.J., Kulchycki, L., Slivka, L.F., Kozik, M., Tary-Lehmann, M. Laughlin, M.J. (2005) Recipient-specific tolerance after HLA-mismatched umbilical cord blood stem cell transplantation. Transplantation, 80, 1316 1322.
23. Klein, J.P. (2002) Survival analysis methods in cancer studies. Cancer Treatment and Research, 113, 37 57.
24. Klein, J.P., Rizzo, J.D., Zhang, M.J. Keiding, N. (2001) Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: regression modeling. Bone Marrow Transplantation, 28, 1001 1011.
25. Kogler, G., Enczmann, J., Rocha, V., Gluckman, E. Wernet, P. (2005) High-resolution HLA typing by sequencing for HLA-A, -B, -C, -DR, -DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome. Bone Marrow Transplantation, 36, 1033 1041.
26. Koh, L.P. Chao, N.J. (2004) Umbilical cord blood transplantation in adults using myeloablative and nonmyeloablative preparative regimens. Biology Blood Marrow Transplant, 10, 1 22.
27. Kurtzberg, J., Laughlin, M., Graham, M.L., Smith, C., Olson, J.F., Halperin, E.C., Ciocci, G., Carrier, C., Stevens, C.E. Rubinstein, P. (1996) Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. New England Journal of Medicine, 335, 157 166.
28. Laughlin, M.J. (2001) Umbilical cord blood for allogeneic transplantation in children and adults. Bone Marrow Transplantation, 27, 1 6.
29. Laughlin, M.J., Barker, J., Bambach, B., Koc, O.N., Rizzieri, D.A., Wagner, J.E., Gerson, S.L., Lazarus, H.M., Cairo, M., Stevens, C.E., Rubinstein, P. Kurtzberg, J. (2001) Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. New England Journal of Medicine, 344, 1815 1822.
30. Laughlin, M.J., Eapen, M., Rubinstein, P., Wagner, J.E., Zhang, M.J., Champlin, R.E., Stevens, C., Barker, J.N., Gale, R.P., Lazarus, H.M., Marks, D.I., van Rood, J.J., Scaradavou, A. Horowitz, M.M. (2004) Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. New England Journal of Medicine, 351, 2265 2275.
31. Lewis, I.D. (2002) Clinical and experimental uses of umbilical cord blood. Internal Medicine Journal, 32, 601 609.
32. Lowdell, M.W. (2003) Natural killer cells in haematopoietic stem cell transplantation. Transfusion Medicine, 13, 399 404.
33. Maraninchi, D., Gluckman, E., Blaise, D., Guyotat, D., Rio, B., Pico, J.L., Leblond, V., Michallet, M., Dreyfus, F. Ifrah, N. (1987) Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias. Lancet, 2, 175 178.
34. Marmont, A.M., Horowitz, M.M., Gale, R.P., Sobocinski, K., Ash, R.C., van Bekkum, D.W., Champlin, R.E., Dicke, K.A., Goldman, J.M. Good, R.A. (1991) T-cell depletion of HLA-identical transplants in leukemia. Blood, 78, 2120 2130.
35. Martin, P., Nash, R., Sanders, J., Leisenring, W., Anasetti, C., Deeg, H.J., Storb, R. Appelbaum, F. (1998) Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation. Bone Marrow Transplantation, 21, 273 279.
36. Mavroudis, D., Read, E., Cottler-Fox, M., Couriel, D., Molldrem, J., Carter, C., Yu, M., Dunbar, C. Barrett, J. (1996) CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood, 88, 3223 3229.
37. Migliaccio, A.R., Adamson, J.W., Stevens, C.E., Dobrila, N.L., Carrier, C.M. Rubinstein, P. (2000) Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood, 96, 2717 2722.
38. Mitsuyasu, R.T., Champlin, R.E., Gale, R.P., Ho, W.G., Lenarsky, C., Winston, D., Selch, M., Elashoff, R., Giorgi, J.V. Wells, J. (1986) Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial. Annals of Internal Medicine, 105, 20 26.
39. Passweg, J.R., Stern, M., Koehl, U., Uharek, L. Tichelli, A. (2005) Use of natural killer cells in hematopoetic stem cell transplantation. Bone Marrow Transplantation, 35, 637 643.
40. Pepe, M.S. Mori, M. (1993) Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Statistics in Medicine, 12, 737 751.
41. Petersdorf, E.W., Anasetti, C., Martin, P.J., Gooley, T., Radich, J., Malkki, M., Woolfrey, A., Smith, A., Mickelson, E. Hansen, J.A. (2004) Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood, 104, 2976 2980.
42. Racadot, E., Herve, P., Beaujean, F., Vernant, J.P., Flesch, M., Plouvier, E., Andreu, G., Rio, B., Philippe, N. Souillet, G. (1987) Prevention of graft-versus-host disease in HLA-matched bone marrow transplantation for malignant diseases: a multicentric study of 62 patients using 3-pan-T monoclonal antibodies and rabbit complement. Journal of Clinical Oncology, 5, 426 435.
43. Ringden, O., Remberger, M., Aschan, J., Lungman, P., Lonnqvist, B. Markling, L. (1994) Long-term follow-up of a randomized trial comparing T cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients. Transplantation, 58, 887 891.
44. Rocha, V., Wagner, J., Sobocinski, K.A., Horowitz, M. Gluckman, E. (1998) Comparative study of graft-versus-host disease in HLA identical sibling cord blood or bone marrow transplant in children. Blood, 92, 685a.
45. Rocha, V., Wagner, Jr., J.E., Sobocinski, K.A., Klein, J.P., Zhang, M.J., Horowitz, M.M. Gluckman, E. (2000) Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. New England Journal of Medicine, 342, 1846 1854.
46. Rocha, V., Labopin, M., Sanz, G., Arcese, W., Schwerdtfeger, R., Bosi, A., Jacobsen, N., Ruutu, T., de Lima, M., Finke, J., Frassoni, F. Gluckman, E. (2004) Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. New England Journal of Medicine, 351, 2276 2285.
47. Rubinstein, P., Rosenfield, R.E., Adamson, J.W. Stevens, C.E. (1993) Stored placental blood for unrelated bone marrow reconstitution. Blood, 81, 1679 1690.
48. Rubinstein, P., Dobrila, L., Rosenfield, R.E., Adamson, J.W., Migliaccio, G., Migliaccio, A.R., Taylor, P.E. Stevens, C.E. (1995) Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proceedings of the National Academy of Sciences of the United States of America, 92, 10119 10122.
49. Rubinstein, P., Carrier, C., Scaradavou, A., Kurtzberg, J., Adamson, J., Migliaccio, A.R., Berkowitz, R.L., Cabbad, M., Dobrila, N.L., Taylor, P.E., Rosenfield, R.E. Stevens, C.E. (1998) Outcomes among 562 recipients of placental-blood transplants from unrelated donors. New England Journal of Medicine, 339, 1565 1577.
50. Sanz, M.A. Sanz, G.F. (2002) Unrelated donor umbilical cord blood transplantation in adults. Leukemia, 16, 1984 1991.
51. Sobocinski, K.A., Horowitz, M.M., Rowlings, P.A., Zhang, M.J., Nugent, M.L., Passweg, J.R., Armitage, J.O., Gale, R.P. Bortin, M.M. (1994) Bone marrow transplantation-1994: a report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. Journal of Hematotherapy, 3, 95 102.
52. Stylianou, J., Vowels, M. Hadfield, K. (2006) Novel cryoprotectant significantly improves the post-thaw recovery and quality of HSC from CB. Cytotherapy, 8, 57 61.
53. Verstegen, M.M., van Hennik, P.B., Terpstra, W., van den Bos, C., Wielenga, J.J., van Rooijen, N., Ploemacher, R.E., Wagemaker, G. Wognum, A.W. (1998) Transplantation of human umbilical cord blood cells in macrophage-depleted SCID mice: evidence for accessory cell involvement in expansion of immature CD34+CD38- cells. Blood, 91, 1966 1976.
54. Wade, J.A., Hurley, C.K., Takemoto, S.K., Thompson, J., Davies, S.M., Fuller, T.C., Rodey, G., Confer, D.L., Noreen, H., Haagenson, M., Kan, F., Klein, J., Eapen, M., Spellman, S. Kollman, C. (2007) HLA mismatching within or outside of cross reactive groups (CREG) is associated with similar outcomes after unrelated hematopoietic stem cell transplant. Blood, 109, 4064 4070.
55. Wagner, J.E., Barker, J.N., DeFor, T.E., Baker, K.S., Blazar, B.R., Eide, C., Goldman, A., Kersey, J., Krivit, W., MacMillan, M.L., Orchard, P.J., Peters, C., Weisdorf, D.J., Ramsay, N.K. Davies, S.M. (2002) Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood, 100, 1611 1618.
56. Yaroslavskiy, B., Colson, Y., Ildstad, S., Parrish, D. Boggs, S.S. (1998) Addition of a bone marrow 'facilitating cell' population increases stem cell-derived cobblestone area formation in impaired long-term bone marrow culture stroma. Experimental Hematology, 26, 604 611.